Treatment-cycle–resolved peripheral blood T-cell GP73 dynamics are associated with clinical benefit during PD-1/PD-L1 inhibitor-based therapy in NSCLC

Lung Cancer · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles